SBN
Click for more information
0.00% 0.0¢ sun biomedical limited

Hi Aj,Could be Stage 2 - or it could be Oraline8. They have been...

  1. vintage
    13,520 Posts.
    lightbulb Created with Sketch. 2703
    clock Created with Sketch.
    19/11/08
    10:20
    Post #: 4512830
    Hi Aj,

    Could be Stage 2 - or it could be Oraline8. They have been keeping the latter under tight wraps (for obvious reasons) until the official launch (tomorrow perhaps).

    We know ketamine abuse is a big issue in China - so I am sure SiYi and the MPS will be most interested in O8. Maybe demos and such.

    Could be some interesting flow-ons into the SiYi JV.

    Whatever it is, it is further building of the alliances.
    SBN Price at posting: 0.6¢ Sentiment: LT Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS MOU executed with leading maritime partner to advance plans for a multi-user transhipping facility in West Pilbara
right-arrow Created with Sketch.
NEWS Oversubscribed share purchase plan successfully raises $2.3 million, with all applications accepted in full
right-arrow Created with Sketch.
NEWS Scoping study unveils promising economics for the Ngami Copper Project, with potential copper resources up to 166Mt — find out more about what makes this a game-changer
right-arrow Created with Sketch.
NEWS ClearVue successfully raises $7.5 million via institutional placement
right-arrow Created with Sketch.
NEWS Canyon-1H well drilling advancing as planned, with promising results observed and key milestones on track for completion by late October
right-arrow Created with Sketch.
NEWS First-ever treatment for Rett syndrome approved in Canada, opening new possibilities for patients and boosting potential royalty payments—discover more about DAYBUE™'s breakthrough
right-arrow Created with Sketch.
watchlist Created with Sketch. Add SBN (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.